Spona, Jürgen <br/><br/>
Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles.  [electronic resource] 

 -  Fertility and sterility  Sep 2010 
 - 1195-1201 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-5653 
<br/><br/><label>Standard No.: </label>10.1016/j.fertnstert.2009.06.057  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Algorithms<br/>Chlormadinone Acetate--administration & dosage<br/>Contraceptives, Oral, Combined--administration & dosage<br/>Dosage Forms<br/>Drug Administration Schedule<br/>Ethinyl Estradiol--administration & dosage<br/>Female<br/>Humans<br/>Menstrual Cycle--drug effects<br/>Ovary--drug effects<br/>Ovulation Inhibition--drug effects<br/>Treatment Outcome<br/>Young Adult